Fig. 3From: Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patientsKaplan-Meier plot of BCSS for CYP2D6 phenotypes. Patients are grouped according to CYP2D6 phenotype group as indicated by the colored lines. Time starting at 3 years after surgery. EM extensive metabolizer, IM intermediate metabolizer, PM poor metabolizer, UM ultra-rapid metabolizerBack to article page